Drug Trial Radar · NCT02179294
A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour
Last checked: Nov 20, 2026Latest source record: Oct 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
401
Actual
Start
May 2014
Primary completion
Sep 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- University of BirminghamAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Heartlands Hospital; Good Hope Hospital; Birmingham Women's NHS Foundation Trust; York Hospital; University Hospital of North Midlands; Frimley Park Hospital; Bradford Royal Infirmary; Stoke Mandeville Hospital; Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK); Medway Maritime Hospital; Northwick Park Hospital; Homerton University Hospital; City Hospital Birmingham; Warwick Hospital; University Hospital Coventry
- First posted
- Jul 1, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Childbirth can be an extremely painful and the provision of pain relief during labour is a vital component of a positive maternal experience. The majority of women who deliver in modern obstetric units choose a pharmacological method of pain relief, including Entonox, the injection of opioids or epidural placement. The commonest opioid used in labour is pethidine administered by intramuscular (im) injection. The effectiveness of pain relief provided by pethidine has long been challenged. Its shortcomings are more serious when set against known side effects including maternal sedation, nausea and potential transfer across the placenta to the foetus. More than a third of women who receive pethidine subsequently require an epidural due to inadequate pain relief. Epidurals provide highly effective pain relief, but increase the risk of a forceps or suction delivery resulting in prolonged hospital stay. Therefore, there is a clear need for a safe, effective, easy to administer analgesic alternative.
Conditions
- Pain Relief in Labour
Interventions
PethidineDrug
100mg by intramuscular injection, up to 4 hourly in frequency (up to a maximum of 4 doses). The maximum dose being 400mg in 24 hours.
RemifentanilDrug
Dedicated intravenous cannula for remifentanil administration PCA protocol * PCA bolus remifentanil 40 μg * Lockout interval 2 minutes In the event of excess sedation being recorded by regular observation of respiratory function, the regimen will be altered by reduction of the remifentanil bolus dose to 30 μg with a lock-out interval of 2 minutes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of women who receive epidural analgesia for pain relief in labour, in each group, after randomisation.Time frame: At labour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Birmingham Clinical Trials Unit
Birmingham, West Midlands, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.